Danaher Q4 Earnings Call Highlights

Molecular diagnostics (Cepheid): FDA clearance for the Xpert GI Panel, a multiplex PCR test that detects 11 gastrointestinal pathogens from a single sample using the GeneXpert platform.Diagnostics (Beckman Coulter Diagnostics): Expansion of the DxI 9000 assay menu, including progress in neurodegenerative disease and a first-to-market automated high-throughput BD-Tau research-use-only immunoassay, alongside additions in cardiac and blood virus menus.Life sciences (SCIEX): Introduction of the ZenoTOF 8600 mas ...